Novartis’ cholesterol med Leqvio wins EU approval
Drug approved to help reduce cholesterol levels
Read More
Tag: inclisiran
Novartis, NHS strike ‘innovative’ cardiovascular deal
Novartis’ inclisiran will be studied in UK patients as part of a large-scale NHS clinical trial, which is expected to start later this year.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
